Hot Alert : API Technologies Corp. (NASDAQ:ATNY), InvenSense, Inc. (NYSE:INVN), FireEye, Inc. (NASDAQ:FEYE), Onconova Therapeutics, Inc. (NASDAQ:ONTX), Google Inc (NASDAQ:GOOGL)

API Technologies Corp (NASDAQ:ATNY) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued on Wednesday. The firm currently has a $2.30 price target on the stock. Zacks‘s price objective suggests a potential upside of 2.22% from the stock’s previous close. API Technologies Corp. (NASDAQ:ATNY) belongs to Technology sector. Its net profit margin is -7.90% and weekly performance is -3.49%. On last trading day company shares ended up $2.21. API Technologies Corp. (NASDAQ:ATNY) distance from 50-day simple moving average (SMA50) is -0.36%.

On Sept. 2, 2014 InvenSense, Inc. (NYSE:INVN) the leading provider of intelligent sensor solutions, announced that, effective Sept. 2, 2014, Alan Krock will depart InvenSense to pursue other opportunities. Krock will assist with the transition and serve as a special advisor through Oct. 31, 2014. Mark P. Dentinger will succeed Krock as InvenSense’ vice president and chief financial officer, effective Sept. 2, 2014. Dentinger will report to Behrooz Abdi, president and chief executive officer. InvenSense, Inc. (NYSE:INVN) shares fell -0.97% in last trading session and ended the day at $23.46. INVN Gross Margin is 48.10% and its return on assets is 3.30%. InvenSense, Inc. (NYSE:INVN) quarterly performance is 10.56%.

FireEye, Inc. (NASDAQ:FEYE) is up 3.25% during pre-market trading , after the company received a Buy rating and price target reiteration from analysts at UBS. The sell-side firm had a previous Neutral rating on FireEye along with a $40 price target. On 12 September, FireEye, Inc. (NASDAQ:FEYE) shares fell -2.77% and was closed at $35.07. FEYE EPS growth in last 5 year was 0.00%. FireEye, Inc. (NASDAQ:FEYE) year to date (YTD) performance is -19.58%.

Onconova Therapeutics, Inc. (NASDAQ:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, announced that Ramesh Kumar, Ph.D., President and CEO, will present at the Rodman & Renshaw 16th Annual Global Investment Conference in New York, NY. The presentation will take place on Wednesday, September 10th at 2:05 p.m. ET. Onconova Therapeutics, Inc. (NASDAQ:ONTX) ended the last trading day at $5.29. Company weekly volatility is calculated as 5.57%and price to cash ratio as 1.63. Onconova Therapeutics, Inc. (NASDAQ:ONTX) showed a weekly performance of 0.38%.

Google Inc (NASDAQ:GOOGL) is in a push to have more app experts from Japan, Rosalind Chin said in a discussion with Rishaad Salamat on Bloomberg’s “On The Move”. In a recent report, said that Chris Yerga, Google Inc (NASDAQ:GOOGL)’s Asia head for the Play Store, has told them that the technology giant is boosting support for app makers from Japan to launch their products outside of the country. Google Inc (NASDAQ:GOOGL) belongs to Technology sector. Its net profit margin is 20.90% and weekly performance is -2.15%. On last trading day company shares ended up $584.90. Google Inc (NASDAQ:GOOGL) distance from 50-day simple moving average (SMA50) is -0.66%.